Results 151 to 160 of about 9,168 (223)

Metabolomics reveals LysoPC a C17:0 (LPC 17:0) as candidate biomarker for personalized medicine in morbid obesity. [PDF]

open access: yesFront Med (Lausanne)
Stefanini E   +8 more
europepmc   +1 more source

Metabolomic Profiling Reveals Brain Lipid Alterations in <i>PEX7</i>-Deficient Models of Rhizomelic Chondrodysplasia Punctata. [PDF]

open access: yesBiomolecules
Sankhe R   +8 more
europepmc   +1 more source

Ceramides in cardiovascular disease: emerging role as independent risk predictors and novel therapeutic targets. [PDF]

open access: yesCardiovasc Res
Klingenberg R   +8 more
europepmc   +1 more source

Metabolic improvement in patients with acid sphingomyelinase deficiency following intravenous trehalose administration: an untargeted pharmacometabolomic study. [PDF]

open access: yesOrphanet J Rare Dis
Khoshakhlagh M   +7 more
europepmc   +1 more source

Bacterial extracellular vesicles as recyclable nutrient reservoirs. [PDF]

open access: yesNat Commun
Laimer-Digruber A   +13 more
europepmc   +1 more source

The Metabolism of Sphingomyelin

open access: yesJournal of Biological Chemistry, 1966
Julian N. Kanfer   +3 more
openaire   +1 more source

A novel prenylflavonoid with efficacy in cancer therapy by targeting ceramide-orchestrated signaling. [PDF]

open access: yesFront Pharmacol
Du R   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy